Heme oxygenase-1 induction may explain the antioxidant profile of pentaerythrityl trinitrate

被引:42
作者
Oberle, S
Abate, A
Grosser, N
Vreman, HJ
Dennery, PA
Schneider, HT
Stalleicken, D
Schröder, H
机构
[1] Univ Halle Wittenberg, Sch Pharm, Dept Pharmacol & Toxicol, D-06099 Halle An Der Saale, Saale, Germany
[2] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA
[3] Univ Appl Sci, Div Pharmacol, D-72488 Sigmaringen, Germany
关键词
antioxidant; bilirubin; carbon monoxide; cell injury; cytoprotection; endothelial cells; gene expression; heme oxygenase; nitric oxide; organic nitrates;
D O I
10.1006/bbrc.2002.6379
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The organic nitrate pentaerythrityl tetranitrate (PETN) is known to exert long-term antioxidant and antiatherogenic effects by as yet unidentified mechanisms. In cultured endothelial cells derived from human umbilical vein, the active PETN metabolite PETriN (0.01-1 mM) increased heme oxygenase (HO)-1 mRNA and protein levels in a concentration-dependent fashion. HO-1 induction was accompanied by a marked increase in catalytic activity of the enzyme as reflected by enhanced formation of carbon monoxide and bilirubin. Pretreatment with PETriN or bilirubin at low micromolar concentrations protected endothelial cells from hydrogen peroxide-mediated toxicity. HO-1 induction and endothelial protection by PETriN were not mimicked by isosorbide dinitrate, another long-acting nitrate. The present study demonstrates that PETriN stimulates mRNA and protein expression as well as enzymatic activity of the antioxidant defense protein HO-1 in endothelial cells. Increased HO-1 expression and ensuing formation of cytoprotective bilirubin may contribute to and explain the specific antioxidant and antiatherogenic actions of PETN. (C) 2002 Elsevier Science (USA).
引用
收藏
页码:1539 / 1544
页数:6
相关论文
共 42 条
[1]   Synergistic inhibition of cyclooxygenase-2 expression by vitamin E and aspirin [J].
Abate, A ;
Yang, G ;
Dennery, PA ;
Oberle, S ;
Schröder, H .
FREE RADICAL BIOLOGY AND MEDICINE, 2000, 29 (11) :1135-1142
[2]   THE ROLE OF NITRATES IN CORONARY HEART-DISEASE [J].
ABRAMS, J .
ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (04) :357-364
[3]  
Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424
[4]  
BOGAERT MG, 1968, ARCH INT PHARMACOD T, V171, P221
[5]   Carbon monoxide in vasoregulation - The promise and the challenge [J].
Coceani, F .
CIRCULATION RESEARCH, 2000, 86 (12) :1184-1186
[6]  
Crandall LA, 1931, J PHARMACOL EXP THER, V41, P103
[7]   BILIARY EXCRETION AND BIOTRANSFORMATION OF PENTAERYTHRITOL TRINITRATTE IN RATS [J].
CREW, MC ;
GALA, RL ;
HAYNES, LJ ;
DICARLO, FJ .
BIOCHEMICAL PHARMACOLOGY, 1971, 20 (11) :3077-&
[8]  
Dikalov S, 1998, J PHARMACOL EXP THER, V286, P938
[9]  
Feelisch M., 1996, M ETHODS NITRIC OXID, P71
[10]   Unexpected, tolerance-devoid vasomotor and platelet actions of pentaerythrityl tetranitrate [J].
Fink, B ;
Bassenge, E .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1997, 30 (06) :831-836